Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

687 studies match

clinicaltrialsPublishedShowing 201–250 of 687 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05987332	IDE196 (Darovasertib) in Combination With Crizotinib as First-line Therapy in Metastatic Uveal Melanoma	active not recruiting	Phase 2 / Phase 3	420	IDEAYA BiosciencesINDUSTRY	13	Feb 17, 2026	clinicaltrials
NCT04895436	Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)(ReVenG)	recruiting	Phase 2	75	AbbVieINDUSTRY	11	Feb 9, 2026